NFE2L2 and Familial prostate cancer: While Nrf2 was activated with isoflavones in stroke patients (almost half of whom were on medication) [62] and fish oil and lycopene in prostate cancer patients [63], in what were large relatively well controlled trials, it would be premature to suggest these populations could benefit from these interventions based on findings from isolated studies.